ArticleArthritis care & research2024

Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.

Melissa L Mannion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.